Atlas Trials

Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis

Clinical trial NCT05254626 · COMPLETED

Trial details

NCT number
NCT05254626
Sponsor
Cairo University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-alcoholic Steatohepatitis
Start date
2022-08-01
Primary completion
2024-01-23
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.